Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1553482
PUBLISHER: Grand View Research | PRODUCT CODE: 1553482
Transfection Reagents & Equipment Market Size, Share & Trends Analysis Report, By Product, By Method (Electroporation), By Application (Transgenic Models), By End-use, By Region, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Transfection Reagents & Equipment Market Growth & Trends:
The global transfection reagents & equipment market size is expected to reach USD 2.19 billion by 2030, registering a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The latest polymeric formulations-based compounds are gentle to cells as compared to cationic liposomes and these products render higher gene-delivery efficiency, further promoting the development of unique transfection products in the market.
Moreover, multi-component reagents such as X-tremeGENE provided by F. Hoffmann-La Roche AG, deliver high efficiency and minimal cytotoxicity than traditional ones comprising only one-component formulations. Thus, companies are keen on offering cutting-edge transfection solutions, in turn, offering significant momentum to market growth.
The gene expression studies segment dominated the market and account for the largest revenue share in 2019. This is attributed to the rising focus on the translation of genomic information in clinics. In addition, an increasing number of research projects related to the identification of chromosomal anomalies is anticipated to propel segment growth.
Transfection Reagents & Equipment Market Report Highlights:
- The reagents segment dominated the transfection reagents and equipment market, with the largest revenue share of 55.4% in 2023.
- The electroporation segment dominated the market in 2023. The broad selection of electroporation solutions from well-known and up-and-coming companies is driving growth in the segment.
- The biomedical research segment is expected to register the fastest CAGR over the forecast period. In recent times, there has been a significant focus on the use of lentivirus for transfection in biomedical research.
- North America dominated with largest revenue share in the transfection reagents and equipment market in 2023. The region is expected to continue this pattern in the forecast time frame.
- Market participants are keen on expanding their product portfolios aimed at sustaining market competition.
- For instance, in July 2019, Mirus Bio launched TransIT-VirusGEN SELECT Transfection Reagent, intended to be used in the drug discovery process in gene and cell manufacturing. The substance simplifies the qualifying process of ancillary materials employed in viral vectors manufacturing for preclinical and early-phase clinical trials.
Product Code: 978-1-68038-715-5
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Transfection Reagents and Equipment Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Transfection Reagents and Equipment Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.1. Porter's Analysis
Chapter 4. Transfection Reagents and Equipment Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Transfection Reagents and Equipment Market: Product Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Reagents
- 4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Equipment
- 4.4.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Transfection Reagents and Equipment Market: Method Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Transfection Reagents and Equipment Market: Method Movement Analysis, 2023 & 2030 (USD Million)
- 5.3. Electroporation
- 5.3.1. Electroporation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Liposomes
- 5.4.1. Liposomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Particle Bombardment
- 5.5.1. Particle Bombardment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Microinjection
- 5.6.1. Microinjection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Adenoviral Vectors
- 5.7.1. Adenoviral Vectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Calcium Phosphate
- 5.8.1. Calcium Phosphate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9. DEAE-dextran
- 5.9.1. DEAE-dextran Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.10. Magnetic Beads
- 5.10.1. Magnetic Beads Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.11. Activated Dendrimers
- 5.11.1. Activated Dendrimers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.12. Laserfection
- 5.12.1. Laserfection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Transfection Reagents and Equipment Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Transfection Reagents and Equipment Market: Application Movement Analysis, 2023 & 2030 (USD Million)
- 6.3. Gene Expression Studies
- 6.3.1. Gene Expression Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Protein Production
- 6.4.1. Protein Production Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Transgenic Models
- 6.5.1. Transgenic Models Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Therapeutic Delivery
- 6.6.1. Therapeutic Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Cancer Research
- 6.7.1. Cancer Research Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. Biomedical Research
- 6.8.1. Biomedical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Transfection Reagents and Equipment: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Transfection Reagents and Equipment Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
- 7.3. Academic and Research Institutes
- 7.3.1. Academic and Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Pharmaceutical and Biotechnological Companies
- 7.4.1. Pharmaceutical and Biotechnological Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Transfection Reagents and Equipment: Regional Estimates & Trend Analysis
- 8.1. Transfection Reagents and Equipment, By Region, 2023 & 2030 (USD Million)
- 8.2. North America
- 8.2.1. North America Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.2. U.S.
- 8.2.2.1. U.S. Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.3. Canada
- 8.2.3.1. Canada Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.4. Mexico
- 8.2.4.1. Mexico Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. UK
- 8.3.2.1. UK Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Germany
- 8.3.3.1. Germany Transfection Reagents and Equipment Market Estimates and Forecasts, 2018- 2030 (USD Million)
- 8.3.4. Italy
- 8.3.4.1. Italy Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.5. Spain
- 8.3.5.1. Spain Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.6. Denmark
- 8.3.6.1. Denmark Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.7. Sweden
- 8.3.7.1. Sweden Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.8. Norway
- 8.3.8.1. Norway Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. Japan
- 8.4.2.1. Japan Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. China
- 8.4.3.1. China Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. India
- 8.4.4.1. India Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. Australia
- 8.4.5.1. Australia Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. South Korea
- 8.4.6.1. South Korea Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Thailand
- 8.4.7.1. Thailand Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Brazil
- 8.5.2.1. Brazil Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Argentina
- 8.5.3.1. Argentina Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Middle East and Africa
- 8.6.1. Middle East and Africa Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. South Africa
- 8.6.2.1. South Africa Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Saudi Arabia
- 8.6.3.1. Saudi Arabia Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. UAE
- 8.6.4.1. UAE Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Kuwait
- 8.6.5.1. Kuwait Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis by Key Market Participants
- 9.2. Company Categorization
- 9.3. Company Heat Map Analysis
- 9.4. Company Profiles
- 9.4.1. Thermo Fisher Scientific, Inc.
- 9.4.1.1. Participant's Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. Promega Corporation
- 9.4.2.1. Participant's Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. Lonza
- 9.4.3.1. Participant's Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. QIAGEN
- 9.4.4.1. Participant's Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. F. Hoffmann-La Roche Ltd.
- 9.4.5.1. Participant's Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. Bio-Rad Laboratories Inc.
- 9.4.6.1. Participant's Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Recent Developments/ Strategic Initiatives
- 9.4.7. Merck KGaA
- 9.4.7.1. Participant's Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Recent Developments/ Strategic Initiatives
- 9.4.8. OriGene Technologies Inc
- 9.4.8.1. Participant's Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Recent Developments/ Strategic Initiatives
- 9.4.9. MaxCyte, Inc.
- 9.4.9.1. Participant's Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Recent Developments/ Strategic Initiatives
- 9.4.10. Polyplus
- 9.4.10.1. Participant's Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Recent Developments/ Strategic Initiatives
- 9.4.1. Thermo Fisher Scientific, Inc.
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.